Descrizione
Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.
Figure 11
ChartSource Paper
An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study.Evidence-based complementary and alternative medicine : eCAM (2012)
PMID: 21747893
DOI: 10.1155/2012/216970
Cite This Figure
![Figure 11: Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.]() > Source: Kadur Ramamurthy Raveendra et al. "An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dys." *Evidence-based complementary and alternative medicine : eCAM*, 2012. PMID: [21747893](https://pubmed.ncbi.nlm.nih.gov/21747893/)
<figure> <img src="" alt="Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period." /> <figcaption>Figure 11. Laboratory safety parameters monitored during the GutGard trial are reported, confirming no significant adverse changes in hepatic or renal function markers during the 30-day treatment period.<br> Source: Kadur Ramamurthy Raveendra et al. "An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dys." <em>Evidence-based complementary and alternative medicine : eCAM</em>, 2012. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/21747893/">21747893</a></figcaption> </figure>